Celebrating early career researchers awarded in the TINs Pilot Data Scheme (PDS) past and present - announcement of 2021 TIN PDS awardees and researcher spotlight event of 2020 awardees in this years UCL Festival of Early Stage Researchers (FESR).
Congratulations to the 26 early career researchers awarded across all 6 modalities, over £269,000 of funding from the UCL/Wellcome Trust Translational Partnership Award.
We would like to recognise these early career researchers for their achievements as listed below:
Biologics - 3 awards (£55,834)
- Christy Hung (UCL GOS ICH, FPHS)
- Jenny Yeung (UCL GOS ICH, FPHS)
- Amy McTague (UCL GOS ICH, FPHS)
Cell & Gene Therapy - 7 awards (£65,464)
- Annalucia Darbey (Institute of Neurology, FBS)
- Mariana Diniz (Infection and Immunity, FMS)
- Hemanth Ramesh Nelvagal (UCL School of Pharmacy, FLS)
- Bernie Simone Owusu-Yaw (Institute for Women’s Health, FPHS)
- Amy Richardson (Institute of Neurology, FBS)
- Matteo Rizzi (Institute of Ophthalmology, FBS)
- Maria Toms (Institute of Ophthalmology, FBS)
Devices & Diagnostics - 6 awards (£52,540)
- Robert Bentham (UCL Cancer Institute, FMS)
- Seyyed Reza (Haqshenas, FEng)
- Liudmyla Storozhuk (MAPS)
- Matthew Wilcox (UCL School of Pharmacy, FLS)
- Sarah Massey (FEng)
- Mikaël Simard (FEng)
Regenerative Medicine - 4 awards (£38,091)
- Ariel Finkielsztein (Institute of Women's Health, FPHS)
- Olga Kopach (Institute of Neurology, FBS)
- Maja Sabalic (Eastman Dental Institute, FMS)
- Maryam Tamaddon (Surgery and Interventional Science, FMS)
Repurposing - 2 awards (£19,180)
- Azadeh Rezaei (Surgery and Interventional Science, FMS)
- Hajrah Sarkar (Institute of Ophthalmology, FBS)
Small Molecules - 4 awards (£37,900)
- Grace Gong (UCL Cancer Institute, FMS)
- Elizabeth Henderson (UCL Cancer Institute, FMS)
- Apostolos Papandreou UCL GOS ICH, FPHS)
- Karin Tuschl (UCL GOS ICH, FPHS)
In addition, we are pleased to announce that the UCL Translational Research Office is part of this years the UCL Festival of Early Stage Researchers (31st Jan – 4th Feb).
We are hosting an event, titled “Early Career Innovators: Highlighting Translational Research Support & Internal Funding Success Stories”, taking place 2.30-4pm on Friday 4th February:
|
|
Here, we will highlight some of the support available through UCL’s Translational Ecosystem, including training and funding opportunities available to UCL Early Stage Researchers. There will also be talks from 3 early career speakers who received pilot data funding scheme (PDS) for their translational projects through the UCL Therapeutic Innovation Networks. They will showcase their project success and describe how the TIN PDS made a real difference to bringing their translational studies to life, as well as the additional, follow-on support gained from across UCL to achieve this.
Please attend if you would to learn about how you can take advantage of upcoming funding and training opportunities from UCL’s translational support system, and hear examples of how other Early Career Researchers utilised this to progress their research steps closer towards the clinic.
|
|
Cell and Gene Therapy
Join over 50 UCL academics and clinicians in representing UCL's strength and capabilities in Cell & Gene Therapy
|
|
|
The Cell & Gene Therapy Therapeutic Innovation Network (TIN) has created on online, internal resource to showcase the diversity/depth and breadth of expertise within the Cell & Gene Therapy space across UCL and our partner hospitals with the aim of facilitating collaborations.
The resource can be accessed below by UCL-only (sign in to view) - we are keen for feedback, so if you have any comments on the structure of this resource and how you might use it going forwards, please contact Helen Cooksley (h.cooksley@ucl.ac.uk).
|
|
|
|
Are you missing from this resource, and would like to demonstrate your capabilities in this modality? Complete the short form below to appear here and raise your profile in the field of Cell & Gene Therapy, not only across UCL but with also with external academic and industrial partners leading to rewarding collaboration and funding opportunities.
|
|
Repurposing
Opportunity to gain support from the Repurposing TIN on the EMA pilot project
|
|
The Repurposing TIN is providing tailored application support for the European Medicines Agency (EMA) pilot project to support the repurposing of medicines, providing regulatory support and advice to help generate a data package robust enough to support a future application by a pharmaceutical company.
It is anticipated that repurposing programmes endorsed by the EMA will attract interest from pharmaceutical industry and other healthcare organisations. Such an endorsement will also increase probability of success in subsequent applications for grants and funding.
|
|
|
If you would like to take advantage of this free offering of support from the Repurposing TIN, please send an expression of interest to Asha Recino (a.recino@ucl.ac.uk) as soon as possible if you haven't already, and the application should be received by Feb 6th at the latest.
For more information about this opportunity, watch our recent Repurposing TIN seminar: Medicines agencies pilot to support Repurposing in academia
|
|
|
External Funding Opportunities
|
|
|
Cell and oligonucleotide therapy fellowship with AstraZeneca
To complement MRC’s existing initiatives in advanced therapies, for example, NATA and UKRMP, there is now an opportunity to pilot an MRC-industry postdoctoral fellowship initiative with AstraZeneca, specifically focused on the shared research priorities of cell and oligonucleotide therapies.
The proposed initial scale of the scheme is support for 10 postdoctoral fellowships of three years’ duration, with a total budget of £4 million.
Funding will support academically-led basic studies focused on research that underpins the development of new cell and oligonucleotide therapies.
The deadline for Expressions of Interest is 4pm TODAY, 28th January 2022.
|
|
|
|
|
